Article Cited by others


Association between cytochrome CYP17A1, CYP3A4, and CYP3A43 polymorphisms and prostate cancer risk and aggressiveness in a Korean study population

Han Jun Hyun, Lee Yong Seong, Kim Hae Jong, Lee Shin Young, Myung Soon Chul

Year : 2015| Volume: 17| Issue : 2 | Page no: 285-291

   This article has been cited by
1 Regulatory genes in the androgen production, uptake and conversion (APUC) pathway in advanced prostate cancer
Sean McSweeney, Hannah E Bergom, Anna Prizment, Susan Halabi, Nima Sharifi, Charles Ryan, Justin Hwang
Endocrine Oncology. 2022; 2(1): R51
[Pubmed]  [Google Scholar] [DOI]
2 Pharmacogenetics of tamoxifen therapy in Asian populations: from genetic polymorphism to clinical outcomes
Tingyu Wang,Yitian Zhou,Guosheng Cao
European Journal of Clinical Pharmacology. 2021;
[Pubmed]  [Google Scholar] [DOI]
3 Polymorphisms of genes related to phase-I metabolic enzymes affecting the clinical efficacy and safety of clopidogrel treatment
Abdullah Alkattan,Eman Alsalameen
Expert Opinion on Drug Metabolism & Toxicology. 2021;
[Pubmed]  [Google Scholar] [DOI]
4 Allele and genotype frequencies of CYP3A4 , CYP3A5 , CYP3A7 , and GSTP1 gene polymorphisms among mainland Tibetan, Mongolian, Uyghur, and Han Chin
Guangzhao Qi, Chao Han, Yubing Zhou, Xin Wang
Clinical and Experimental Pharmacology and Physiology. 2021;
[Pubmed]  [Google Scholar] [DOI]
5 Genetic variants in xenobiotic detoxification enzymes, antioxidant defenses and hormonal pathways as biomarkers of susceptibility to prostate cancer
L.J. Martinez-Gonzalez,A. Antúnez-Rodríguez,F. Vazquez-Alonso,A.F. Hernandez,M.J. Alvarez-Cubero
Science of The Total Environment. 2020; 730: 138314
[Pubmed]  [Google Scholar] [DOI]
6 Altered expression of cytochrome P450 enzymes involved in metabolism of androgens and vitamin D in the prostate as a risk factor for prostate cancer
Oksana V. Maksymchuk,Vladimir I. Kashuba
Pharmacological Reports. 2020;
[Pubmed]  [Google Scholar] [DOI]

Association Between CYP17A1, CYB5A Polymorphisms and Efficacy of Abiraterone Acetate/Prednisone Treatment in Castration-Resistant Prostate Cancer Patients

Xiang Wu,Qing-Jiang Xu,Ping-Zhou Chen,Chen-Bo Yu,Lie-Fu Ye,Tao Li
Pharmacogenomics and Personalized Medicine. 2020; Volume 13: 181
[Pubmed]  [Google Scholar] [DOI]
8 Structural perspectives of the CYP3A family and their small molecule modulators in drug metabolism
William C. Wright,Jude Chenge,Taosheng Chen
Liver Research. 2019;
[Pubmed]  [Google Scholar] [DOI]
9 Characterization of Genetic Variation in CYP3A4 on the Metabolism of Cabozantinib in Vitro
Qian-meng Lin,Ying-hui Li,Xiang-ran Lu,Ru Wang,Ni-hong Pang,Ren-ai Xu,Jian-ping Cai,Guo-xin Hu
Chemical Research in Toxicology. 2019;
[Pubmed]  [Google Scholar] [DOI]
10 The incidence, mortality, and risk factors of prostate cancer in Asian men
Byung Ha Chung,Shigeo Horie,Edmund Chiong
Prostate International. 2018;
[Pubmed]  [Google Scholar] [DOI]
11 Sequence-Based Analysis of Lipid-Related Metabolites in a Multiethnic Study
Elena V. Feofanova,Bing Yu,Ginger A. Metcalf,Xiaoming Liu,Donna Muzny,Jennifer E. Below,Lynne E. Wagenknecht,Richard A. Gibbs,Alanna C. Morrison,Eric Boerwinkle
Genetics. 2018; 209(2): 607
[Pubmed]  [Google Scholar] [DOI]
12 A Study on the Association Between Polymorphisms in the Cytochrome P450 Family 17 Subfamily A Member 1 Gene Region and Type 2 Diabetes Mellitus in Han Chinese
Long Wang,Yu-Ming Niu,Shi-Shi Wu,Chao Zhang,Li Zhou,Hong-Xia Zuo,Peng Wang
Frontiers in Endocrinology. 2018; 9
[Pubmed]  [Google Scholar] [DOI]
13 The associations of genetic polymorphisms in CYP1A2 and CYP3A4 with clinical outcomes of breast cancer patients in northern China
Xianan Bai,Jingjing Xie,Shanshan Sun,Xianyu Zhang,Yongdong Jiang,Da Pang
Oncotarget. 2017; 8(24): 38367
[Pubmed]  [Google Scholar] [DOI]
14 Systematic screening for CYP3A4 genetic polymorphisms in a Han Chinese population
Guo-Xin Hu,Da-Peng Dai,Hao Wang,Xiang-Xin Huang,Xiao-Yang Zhou,Jie Cai,Hao Chen,Jian-Ping Cai
Pharmacogenomics. 2017; 18(4): 369
[Pubmed]  [Google Scholar] [DOI]


Read this article